References for Post-Transplant Medications for Clinicians

1. Abu-Elmagd KM, Costa G, Bond GJ, et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int. 2009;22(1):96-109. doi:10.1111/j.1432-2277.2008.00785.x

2. Hashimoto K, Costa G, Khanna A, Fujiki M, Quintini C, Abu-Elmagd K. Recent Advances in Intestinal and Multivisceral Transplantation. Adv Surg. 2015;49:31-63. doi:10.1016/j.yasu.2015.04.003

3. Bond GJ, Mazariegos GV, Sindhi R, Abu-Elmagd KM, Reyes J. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg. 2005;40(1):274-280. doi:10.1016/j.jpedsurg.2004.09.020

4. Florescu DF, Abu-Elmagd K, Mercer DF, Qiu F, Kalil AC. An international survey of cytomegalovirus prevention and treatment practices in intestinal transplantation. Transplantation. 2014;97(1):78-82. doi:10.1097/TP.0b013e3182a6baa2

5. Fishbein TM. Intestinal transplantation [published correction appears in N Engl J Med. 2009 Oct 1;361(14):1416]. N Engl J Med. 2009;361(10):998-1008. doi:10.1056/NEJMra0804605

6. Silva JT, San-Juan R, Fernández-Caamaño B, et al. Infectious Complications Following Small Bowel Transplantation. Am J Transplant. 2016;16(3):951-959. doi:10.1111/ajt.13535

7. Khan A, El-Charabaty E, El-Sayegh S. Fungal infections in renal transplant patients. J Clin Med Res. 2015;7(6):371-378. doi:10.14740/jocmr2104w

8. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg. 2001;234(3):404-417. doi:10.1097/00000658-200109000-00014

9. Abu-Elmagd K. The concept of gut rehabilitation and the future of visceral transplantation. Nat Rev Gastroenterol Hepatol. 2015;12(2):108-120. doi:10.1038/nrgastro.2014.216